Novo Nordisk, whose shares have stumbled this year, on Tuesday announced a positive trial result for a weight-loss drug in ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

Researchers say a woman struggling with obesity who couldn't resist eating fatty foods experienced declines in her cravings after taking tirzepatide.

The researcher also looked at what DCA does directly to fat cells. Using a standard fat cell line grown in the laboratory, ...

Tons of celebs have praised the “miracle drug,” while others have acknowledged the less-than-glamorous reality of using it.

Eli Lilly said on Friday it plans to roll out an employer-focused obesity care model early next year, aiming to expand access ...

With one in eight adults taking drugs like Ozempic and Mounjaro, emerging evidence shows that the medication has potential to ...

Something profound is happening in Canada’s food economy, and most people haven’t quite grasped it yet. It’s not a new grocer ...

Shares of Mangoceuticals surged 28% ‌to $2.25 in premarket trading. U.S. regulations allow compounding pharmacies to copy ...

OneSource Specialty Pharma has raised its FY28 revenue forecast from $400 million to over $500 million, driven by strong ...

While society's obsession with female bodies is nothing new, a wave of celebrities who embraced their larger bodies are ...

CEO Siddharth Mittal believes Biocon’s existing portfolio, including liraglutide, gives it an edge in a highly competitive ...